Shah Jalal Uddin Ahmed, managing director of Techno Drugs, which is a new transaction in the stock market, said, that after a long process, we have been able to get listed in the stock market, it is our success. Which will help in expanding our business.
Addressing the investors, he said, “I hope we can give something good to the investors through the proper use of the money raised through the initial public offering (IPO).”
The MD of the company said these things at the signing ceremony of the listing agreement of Techno Drugs Limited with Dhaka Stock Exchange PLC (DSE) on Sunday (July 14).
A news release from DSE on Monday (July 15) stated this expectation. In the agreement signing ceremony, DSE Chief Regulatory Officer Khairul Bashar Abu Taher Mohammad and Techno Drugs Managing Director Shah Jalal Uddin Ahmed signed the agreement on behalf of their respective organizations.
The Deputy General Manager of the Publication and Public Relations Department of DSE was present at the contract signing ceremony among others. Shafikur Rahman, Assistant General Manager and Head of Listing Affairs Department. Rabiul Islam, Techno Drugs Chairman Khaleda Aktan Khan, and other directors, Imperial Capital CEO AB Parvez.
In his welcome speech, DSE Chief Regulatory Officer Khairul Bashar Abu Taher Mohammad said that there was a record amount of subscriptions in the Techno Drug IPO. Which has increased the responsibility of DSE. They have to properly follow the post-listing procedures and compliance matters of listing in DSE. At the same time, we hope that the company will be able to repay the investors’ trust.
It may be noted that on July 2, 2024 shares of Techno Drugs were allocated on a pro-rata basis as the 100th issue to common investors through the Stock Exchange Electronic Subscription System (ESS)
Chairman of DSE Professor Dr. In the case of Hafiz Muhammad Hasan Babu IPO application, the company received an application of Tk 2487 crore 18 thousand 104 against a total of Tk 100 crore, which is 24.64 times more. Resident Bangladeshi investors get 11 shares and non-resident Bangladeshi investors get 20 shares against every Tk 10,000 applied.
